Učitavanje...
Long-term Outcome of (Neo)adjuvant Zoledronic Acid Therapy in Locally Advanced Breast Cancer
PURPOSE: The role of zoledronic acid (ZOL), a bone-targeted bisphosphonate, in the treatment of patients with breast cancer remains an active area of study. Here, we report the long-term outcomes of a randomized placebo-controlled phase II clinical trial in which ZOL treatment was added to neoadjuva...
Spremljeno u:
| Izdano u: | Breast Cancer Res Treat |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8068643/ https://ncbi.nlm.nih.gov/pubmed/33591469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06100-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|